CA2588221C - Polypeptides chimeriques modifies a pharmacocinetique amelioree - Google Patents

Polypeptides chimeriques modifies a pharmacocinetique amelioree Download PDF

Info

Publication number: CA2588221C
Authority: CA; Canada
Prior art keywords: ser; leu; thr; val; lys
Prior art date: 1999-06-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA2588221A

Other languages

English (en)

Other versions

CA2588221A1 (fr

Inventor

George D. Yancopoulos

Samuel Davis

Nicholas J. Papadopoulos

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Regeneron Pharmaceuticals Inc

Original Assignee

Regeneron Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-08

Filing date

2000-05-23

Publication date

2013-07-09

2000-05-23 Application filed by Regeneron Pharmaceuticals Inc filed Critical Regeneron Pharmaceuticals Inc

2000-05-23 Priority claimed from CA002376379A external-priority patent/CA2376379C/fr

2000-12-14 Publication of CA2588221A1 publication Critical patent/CA2588221A1/fr

2013-07-09 Application granted granted Critical

2013-07-09 Publication of CA2588221C publication Critical patent/CA2588221C/fr

2020-05-23 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Landscapes

Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CA2588221A 1999-06-08 2000-05-23 Polypeptides chimeriques modifies a pharmacocinetique amelioree Expired - Lifetime CA2588221C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US13813399P	1999-06-08	1999-06-08
US60/138,133		1999-06-08
CA002376379A CA2376379C (fr)	1999-06-08	2000-05-23	Polypeptides chimeriques modifies a pharmacocinetique amelioree

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002376379A Division CA2376379C (fr)	1999-06-08	2000-05-23	Polypeptides chimeriques modifies a pharmacocinetique amelioree

Publications (2)

Publication Number	Publication Date
CA2588221A1 CA2588221A1 (fr)	2000-12-14
CA2588221C true CA2588221C (fr)	2013-07-09

Family

ID=38326379

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2588221A Expired - Lifetime CA2588221C (fr)	1999-06-08	2000-05-23	Polypeptides chimeriques modifies a pharmacocinetique amelioree

Country Status (1)

Country	Link
CA (1)	CA2588221C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201705484D0 (en) *	2017-04-05	2017-05-17	Quethera Ltd	Genetic construct

2000
- 2000-05-23 CA CA2588221A patent/CA2588221C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2588221A1 (fr)	2000-12-14

Publication	Publication Date	Title
CA2376379C (fr)	2007-08-07	Polypeptides chimeriques modifies a pharmacocinetique amelioree
US7704500B2 (en)	2010-04-27	Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides
CA2588221C (fr)	2013-07-09	Polypeptides chimeriques modifies a pharmacocinetique amelioree
HK1043388B (en)	2005-06-10	Modified chimeric polypeptides with improved pharmacokinetic properties
HK1132653B (en)	2013-09-13	Modified chimeric polypeptides with improved pharmacokinetic properties

Legal Events

Date	Code	Title	Description
2007-05-17	EEER	Examination request
2020-07-26	MKEX	Expiry	Effective date: 20200523